Clinical and anamnestic characteristics of infertile patients with ovarian endometriomas in assisted reproductive technology programs

In: REPRODUCTIVE ENDOCRINOLOGY · 2026 · pp. 68–72 · doi:10.18370/2309-4117.2026.85.68-72 · W7223567378
Observational OA: diamond CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-10-27 ⓘ

This retrospective study of infertile patients in assisted reproductive technology programs found that untreated ovarian endometriomas were associated with lower anti-Müllerian hormone and higher estradiol levels compared to surgically treated or control groups.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-27 · read from full text ⓘ

This retrospective cohort study evaluated the clinical, anamnestic, and hormonal characteristics of 67 infertile patients undergoing assisted reproductive technology, comparing those with treated ovarian endometriomas, untreated ovarian endometriomas, and a control group without endometriosis. The results indicated that patients with ovarian endometriomas exhibited higher rates of primary infertility, dysmenorrhea, and menstrual cycle disorders compared to controls. Specifically, untreated endometriomas were associated with significantly lower anti-Müllerian hormone levels and higher estradiol levels than both surgically treated patients and the control group. This paper is centrally about endometriosis — specifically focusing on the impact of ovarian endometriomas and prior surgical treatment on ovarian reserve markers in infertile patients seeking assisted reproductive technology.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Objective of the study: to evaluate the clinical, anamnestic, reproductive, and hormonal characteristics of infertile patients with ovarian endometriomas depending on prior surgical treatment in assisted reproductive technology.Materials and methods. A retrospective cohort study was conducted involving 67 infertile patients who underwent evaluation and treatment using assisted reproductive technology programs between 2024 and 2026. Group 1 included 24 patients with ovarian endometriomas following surgical treatment; Group 2 included 23 patients with untreated ovarian endometriomas; and Group 3, the control group, included 20 patients with male-factor and/or absolute tubal infertility without endometriosis. Results. No statistically significant differences in age were found between the groups. At the same time, the groups differed in body mass index, age at menarche, and duration of infertility. Primary infertility was more common in patients with ovarian endometriomas, whereas secondary infertility predominated in the control group. Patients with endometriomas typically presented with dysmenorrhea and pre- and postmenstrual bleeding. The highest incidence of dysmenorrhea was observed in the group with untreated endometriomas. Regarding hormonal profile indicators, statistically significant differences were found in the levels of anti-Müllerian hormone and estradiol. The lowest anti-Müllerian hormone level was found in patients with endometriomas (0.61 ± 0.07 ng/mL), whereas in patients who had undergone surgical treatment it was 1.67 ± 0.28 ng/mL, and in the control group – 1.38 ± 0.14 ng/mL. Estradiol levels were highest in Group 2 – 143.5 ± 40.1 pg/mL. Conclusions. Infertile patients with ovarian endometriomas exhibit characteristic clinical and anamnestic features, including a higher prevalence of primary infertility, dysmenorrhea, and menstrual cycle disorders. The presence of untreated ovarian endometriomas was associated with a statistically significant decrease in anti-Müllerian hormone levels and an increase in estradiol levels. The results confirm the need for an individualized assessment of reproductive potential and ovarian reserve when planning assisted reproductive technology in patients with ovarian endometriomas.
Full text 9,097 characters · extracted from oa-html · 3 sections · click to expand

Objective

of the study: to evaluate the clinical, anamnestic, reproductive, and hormonal characteristics of infertile patients with ovarian endometriomas depending on prior surgical treatment in assisted reproductive technology.

Materials

and methods. A retrospective cohort study was conducted involving 67 infertile patients who underwent evaluation and treatment using assisted reproductive technology programs between 2024 and 2026. Group 1 included 24 patients with ovarian endometriomas following surgical treatment; Group 2 included 23 patients with untreated ovarian endometriomas; and Group 3, the control group, included 20 patients with male-factor and/or absolute tubal infertility without endometriosis. Results. No statistically significant differences in age were found between the groups. At the same time, the groups differed in body mass index, age at menarche, and duration of infertility. Primary infertility was more common in patients with ovarian endometriomas, whereas secondary infertility predominated in the control group. Patients with endometriomas typically presented with dysmenorrhea and pre- and postmenstrual bleeding. The highest incidence of dysmenorrhea was observed in the group with untreated endometriomas. Regarding hormonal profile indicators, statistically significant differences were found in the levels of anti-Müllerian hormone and estradiol. The lowest anti-Müllerian hormone level was found in patients with endometriomas (0.61 ± 0.07 ng/mL), whereas in patients who had undergone surgical treatment it was 1.67 ± 0.28 ng/mL, and in the control group – 1.38 ± 0.14 ng/mL. Estradiol levels were highest in Group 2 – 143.5 ± 40.1 pg/mL. Conclusions. Infertile patients with ovarian endometriomas exhibit characteristic clinical and anamnestic features, including a higher prevalence of primary infertility, dysmenorrhea, and menstrual cycle disorders. The presence of untreated ovarian endometriomas was associated with a statistically significant decrease in anti-Müllerian hormone levels and an increase in estradiol levels. The results confirm the need for an individualized assessment of reproductive potential and ovarian reserve when planning assisted reproductive technology in patients with ovarian endometriomas.

References

- World Health Organization. Infertility [Internet]. Geneva: WHO; 2023 [cited 2026 Aug 26]. Available from: https://www.who.int/news-room/fact-sheets/detail/infertility - Becker CM, Bokor A, Heikinheimo O, Horne A, Jansen F, Kiesel L, et al. ESHRE guideline: endometriosis. Hum Reprod Open. 2022;2022(2):hoac009. DOI:10.1093/hropen/hoac009 - Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet. 2021 Feb 27;397(10276):839–52. DOI: 10.1016/S0140-6736(21)00389-5 - International Working Group of AAGL, ESGE, ESHRE and WES; Tomassetti C, Johnson NP, Petrozza J, Abrao MS, Einarsson JI, Horne AW, Lee TTM, Missmer S, Vermeulen N, Zondervan KT, Grimbizis G, De Wilde RL. An international terminology for endometriosis, 2021. Hum Reprod Open. 2021 Oct 22;2021(4):hoab029. DOI: 10.1093/hropen/hoab029 - Chapron C, Marcellin L, Borghese B, Santulli P. Rethinking mechanisms, diagnosis and management of endometriosis. Nat Rev Endocrinol. 2019 Nov;15(11):666-682. DOI: 10.1038/s41574-019-0245-z - Vercellini P, Viganò P, Bandini V, Buggio L, Berlanda N, Somigliana E. Association of endometriosis and adenomyosis with pregnancy and infertility. Fertil Steril. 2023 May;119(5):727-740. DOI: 10.1016/j.fertnstert.2023.03.018 - Keckstein J, Hoopmann M, Merz E, Grab D, Weichert J, Helmy-Bader S, et al. Expert opinion on the use of transvaginal sonography for presurgical staging and classification of endometriosis. Arch Gynecol Obstet. 2023 Jan;307(1):5–19. DOI: 10.1007/s00404-022-06766-z - Gniadek M, Porubenska A, Pełka K, Rzepkowska Z, Florjański J. Endometriosis-Associated Infertility: A Review of Pathophysiological Mechanisms and Current Treatment Strategies. J Clin Med. 2026 Jun 2;15(11):4297. DOI: 10.3390/jcm15114297 - Hernández A, Sanz A, Spagnolo E, Lopez A, Martínez Jorge P, Iniesta S, et al. Impact of Ovarian Endometrioma and Surgery on Reproductive Outcomes: A Single-Center Spanish Cohort Study. Biomedicines. 2023 Mar 10;11(3):844. DOI: 10.3390/biomedicines11030844 - Gayete-Lafuente S, Vilà Famada A, Albayrak N, Espinós Gómez JJ, Checa Vizcaíno MÁ, Moreno-Sepulveda J. Indirect markers of oocyte quality in patients with ovarian endometriosis undergoing IVF/ICSI: a systematic review and meta-analysis. Reprod Biomed Online. 2024 Sep;49(3):104075. DOI: 10.1016/j.rbmo.2024.104075 - Colombi I, Ginetti A, Cannoni A, Cimino G, d’Abate C, Schettini G, et al. Combine Surgery and In Vitro Fertilization (IVF) in Endometriosis-Related Infertility: When and Why. J Clin Med. 2024 Dec 2;13(23):7349. DOI: 10.3390/jcm13237349 - Elizur SE, Aizer A, Yonish M, Shavit T, Orvieto R, Mashiach R, et al. Fertility preservation for women with ovarian endometriosis: results from a retrospective cohort study. Reprod Biomed Online. 2023 Feb;46(2):332-337. DOI: 10.1016/j.rbmo.2022.11.014 - Kheil MH, Sharara FI, Ayoubi JM, Rahman S, Moawad G. Endometrioma and assisted reproductive technology: a review. J Assist Reprod Genet. 2022 Feb;39(2):283-290. DOI: 10.1007/s10815-022-02403-5 - Muzii L, Di Tucci C, Di Feliciantonio M, Galati G, Verrelli L, Donato VD, et al. Erratum: Management of Endometriomas. Semin Reprod Med. 2017 Jul;35(4):390-392. DOI: 10.1055/s-0037-1606279 - Manu A, Poenaru E, Duica F, Stoleru S, Bausic AIG, Coroleuca BC, et al. Impact of Minimally Invasive Surgery on Quality of Life and Infertility in Deep Infiltrating Endometriosis. J Clin Med. 2025 Oct 14;14(20):7256.DOI: 10.3390/jcm14207256 - Daniilidis A, Angioni S, Di Michele S, Dinas K, Gkrozou F, D’Alterio MN. Deep Endometriosis and Infertility: What Is the Impact of Surgery? J Clin Med. 2022 Nov 14;11(22):6727. DOI: 10.3390/jcm11226727 - Bafort C, Beebeejaun Y, Tomassetti C, Bosteels J, Duffy JM. Laparoscopic surgery for endometriosis. Cochrane Database Syst Rev. 2020 Oct 23;10(10):CD011031. DOI: 10.1002/14651858.CD011031.pub3 - Jiang D, Nie X. Effect of endometrioma and its surgical excision on fertility (Review). Exp Ther Med. 2020 Nov;20(5):114. DOI: 10.3892/etm.2020.9242. - Liu W, Zhao T, Zheng Z, Huang J, Tan J. Comparison of ovarian reserve after laparoscopic cystectomy in patients with ovarian endometriosis differ in cyst size: A systematic review and meta-analysis. Int J Gynaecol Obstet. 2025 Jul;170(1):86-100. DOI: 10.1002/ijgo.16147 - Daniilidis A, Grigoriadis G, Kalaitzopoulos DR, Angioni S, Kalkan Ü, Crestani A, et al. Surgical Management of Ovarian Endometrioma: Impact on Ovarian Reserve Parameters and Reproductive Outcomes. J Clin Med. 2023 Aug 16;12(16):5324. DOI: 10.3390/jcm12165324 - La Marca A, Semprini M, Mastellari E, Donno V, Capuzzo M, Alboni C, et al. Fertility preservation in women with endometriosis. Hum Reprod Open. 2025 Feb 28;2025(2):hoaf012. DOI: 10.1093/hropen/hoaf012 - Zeng C, Lu R, Li X, Kuai Y, Wang S, Xue Q. The presence of ovarian endometrioma adversely affect ovarian reserve and response to stimulation but not oocyte quality or IVF/ICSI outcomes: a retrospective cohort study. J Ovarian Res. 2022 Oct 22;15(1):116. DOI: 10.1186/s13048-022-01042-9 - Goyri E, Kohls G, Garcia-Velasco J. IVF stimulation protocols and outcomes in women with endometriosis. Best Pract Res Clin Obstet Gynaecol. 2024 Feb;92:102429. DOI: 10.1016/j.bpobgyn.2023.102429 - Kotlyar AM, Seifer DB. Women with endometriosis who undergo IVF: a contemporary review of therapeutic strategies for successful outcomes. Reprod Biol Endocrinol. 2025 Dec 4;24(1):1. DOI: 10.1186/s12958-025-01506-9 - Yong PJ, Allaire C, Bedaiwy M, Bougie O, Kives S, Maheux-Lacroix S, et al. Guideline No. 468: Clinical Management of Endometriosis. J Obstet Gynaecol Can. 2026 Jun;48(6):103382. DOI: 10.1016/j.jogc.2026.103382 Downloads Published How to Cite Issue Section License This work is licensed under a Creative Commons Attribution 4.0 International License. Authors who publish with this journal agree to the following terms: - Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. - Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-10-29T06:07:36.237560+00:00
License: CC0 · commercial use OK